Literature DB >> 16242312

An audit into the efficacy of single use bacterial/viral filters for the prevention of equipment contamination during lung function assessment.

M Unstead1, M D Stearn, D Cramer, M V Chadwick, R Wilson.   

Abstract

Lung function testing has been suggested to provide a potential risk regarding cross-infection between patients. About 155 patients (86 infectious, 69 non-infectious) used a single use bacterial/viral filter when performing routine lung function tests. Swabs from the patient side of the filter (Proximal) and the equipment side (Distal), and two sections of the filter itself were cultured. About 33/155 samples showed bacterial growth on the Proximal compared with 2/155 on the Distal side (P<0.01). Growth was obtained from the filter in 125/155 (80.6%) of cases. Pathogenic micro-organisms such as Pseudomonas aeruginosa (4 cases) and Staphylococcus aureus (5 cases) were isolated. Appropriate infection control measures should be used when performing lung function tests.

Entities:  

Mesh:

Year:  2005        PMID: 16242312     DOI: 10.1016/j.rmed.2005.09.015

Source DB:  PubMed          Journal:  Respir Med        ISSN: 0954-6111            Impact factor:   3.415


  4 in total

Review 1.  Infection control in the pulmonary function test laboratory.

Authors:  Shweta Amol Rasam; Komalkirti Keshavkiran Apte; Sundeep Santosh Salvi
Journal:  Lung India       Date:  2015 Jul-Aug

Review 2.  International consensus on lung function testing during the COVID-19 pandemic and beyond.

Authors:  Aisling McGowan; Pierantonio Laveneziana; Sam Bayat; Nicole Beydon; P W Boros; Felip Burgos; Matjaž Fležar; Monika Franczuk; Maria-Alejandra Galarza; Adrian H Kendrick; Enrico Lombardi; Jellien Makonga-Braaksma; Meredith C McCormack; Laurent Plantier; Sanja Stanojevic; Irene Steenbruggen; Bruce Thompson; Allan L Coates; Jack Wanger; Donald W Cockcroft; Bruce Culver; Karl Sylvester; Frans De Jongh
Journal:  ERJ Open Res       Date:  2022-03-07

Review 3.  Pulmonary function testing during SARS-CoV-2: An ANZSRS/TSANZ position statement.

Authors:  Brigitte M Borg; Christian Osadnik; Keith Adam; David G Chapman; Catherine E Farrow; Vanda Glavas; Kerry Hancock; Celia J Lanteri; Ewan G Morris; Nicholas Romeo; Elena K Schneider-Futschik; Hiran Selvadurai
Journal:  Respirology       Date:  2022-08-10       Impact factor: 6.175

4.  Spirometry in COVID-19 Times - An Emerging Dilemma.

Authors:  K R Bharath Kumar Reddy; G V Basavaraja; Barnali G Bhattacharya
Journal:  Indian Pediatr       Date:  2020-08-15       Impact factor: 1.411

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.